Kansas Bioscience Authority Bldg.
10900 S. Clay Blair Blvd., Ste. 1000
Olathe, KS 66061
Phone: (877) 682-2673
Email: [email protected]
Website: www.biova.com
Discover Why Biova is the Clear Choice
Privately held, Biova applies advanced research and technology to develop innovative egg-membrane based commercial ingredients for customers worldwide. Sustainable production, anchored by vertical integration with some of the largest U.S. egg producing and processing partners assures Biova unmatched raw material supply—the right combination of access and capability to drive opportunity and growth.
Key Technology
Founded on innovative technological research, Biova holds multiple patents, including:
• OvaPure: Biova’s patented technology for separating nutrient-rich egg membrane from eggshells. OvaPure is an eco-friendly process ensuring the egg membrane’s natural nutrient matrix remains intact while leaving minimal calcium residue.
• Hydro5: Biova’s proprietary, patented hydrolyzation process for making egg membrane water soluble, while retaining natural nutrient ratios. The Hydro5 process assures uniform ingredient profiling for consistent formulations and better products.
These two processes are integral to creating Ovacore, the world’s leading water soluble egg membrane (WSEM) material for commercial application. Standardized at ≥85 percent protein, Ovacore’s natural nutrient ratio contains beneficial proteins (e.g., elastin ≥20 percent), collagens (e.g., total collagen ≥20 percent), and glycosaminoglycans (e.g., chondroitin sulfate glucosamine; total GAGs ≥8 percent). Hydro5 processing means Ovacore has only minimal calcium remnants for low-ash content. Supported by benchmark pilot studies, plus ongoing research efforts, Ovacore-based ingredients provide a perfect natural active for cosmetic, pharmaceutical, animal health and nutritional health applications (supplement, plus functional food).
Key Products
For human product applications, Biova offers the following 100 percent made in the U.S., WSEM branded ingredients:
BiovaFlex supports the stability and flexibility of synovial joint functions. It features natural nutrient ratios of beneficial proteins (e.g., elastin), collagens and glycosaminoglycans (e.g., chondroitin-sulfate, glucosamine). Preliminary clinical trials demonstrate fast five-day results matched by sustained 60-day support. Further, BiovaFlex has shown WOMAC reductions of 20 percent, plus improved functional flexibility by 19 percent, all within 14 days.
BiovaDerm targets connective, epithelial and neural tissue functional support, plus support for healthy skin tonality and moisture retention. BiovaDerm is elementally rich in glycosaminoglycans, dermatan sulfate, chondroitin-4-sulfate and other elements including ovotransferrin, 3-desmosine, isodesmosine, lysyl oxidase and lysozome. Preliminary research shows BiovaDerm resulted in up to 50 percent reductions in the appearance of deep skin wrinkles in as little as 14 days.
For the companion pet market Biova offers:
• BiovaPlex: designed for canine, feline, equine health applications. Its natural matrix of collagen, elastin, desmosine, isodesmosine and glycosaminoglycans is clinically shown to improve joint support and coat condition. Canine research has shown improved joint mobility within seven days. Water solubility makes BiovaPlex optimal for a variety of companion pet finished goods.
Quality Assurance
Biova’s Ovacore-based products are GRAS (generally recognized as safe), and manufactured in a certified cGMP (current good manufacturing practice) production facility. This facility and the entire line of WSEM ingredients are also kosher and halal certified.
Key Personnel
• Matt Stegenga, President
• Craig Rowles, DVM, COO
• Kathy Hockla, Project Manager
• Chris Groutt, Domestic Sales Manager
• Allen Levine, International Sales Manager
Applied Science. Innovative Ingredients. Better Products. Naturally.
